REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 86 filers reported holding REVANCE THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 1.69 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $78,195,000 | -8.4% | 2,806,712 | -2.5% | 0.61% | -4.8% |
| Q2 2021 | $85,367,000 | -3.4% | 2,880,119 | -9.0% | 0.64% | -2.7% |
| Q1 2021 | $88,413,000 | +5.2% | 3,163,255 | +6.7% | 0.66% | +1.5% |
| Q4 2020 | $84,004,000 | +20.9% | 2,964,135 | +7.3% | 0.65% | -1.7% |
| Q3 2020 | $69,457,000 | -20.5% | 2,762,806 | -22.8% | 0.66% | -26.7% |
| Q2 2020 | $87,417,000 | +55.8% | 3,579,711 | -5.6% | 0.90% | +22.5% |
| Q1 2020 | $56,102,000 | -28.6% | 3,790,648 | -21.7% | 0.74% | +5.4% |
| Q4 2019 | $78,564,000 | +25.1% | 4,840,636 | +0.2% | 0.70% | +11.5% |
| Q3 2019 | $62,811,000 | +12.3% | 4,831,653 | +12.1% | 0.63% | +16.8% |
| Q2 2019 | $55,914,000 | +4.1% | 4,310,996 | +26.5% | 0.54% | +6.1% |
| Q1 2019 | $53,729,000 | +15.5% | 3,409,217 | +47.5% | 0.51% | +3.7% |
| Q4 2018 | $46,518,000 | -16.6% | 2,310,903 | +3.0% | 0.49% | +4.5% |
| Q3 2018 | $55,755,000 | +12.6% | 2,243,655 | +24.4% | 0.47% | +2.6% |
| Q2 2018 | $49,527,000 | -7.4% | 1,804,275 | +4.0% | 0.46% | -14.8% |
| Q1 2018 | $53,460,000 | -13.9% | 1,735,699 | -0.1% | 0.53% | -15.1% |
| Q4 2017 | $62,088,000 | +5.5% | 1,736,734 | -18.7% | 0.63% | -5.8% |
| Q3 2017 | $58,834,000 | +8.9% | 2,135,521 | +4.4% | 0.67% | -0.1% |
| Q2 2017 | $54,011,000 | +34.8% | 2,045,862 | +6.2% | 0.67% | +22.3% |
| Q1 2017 | $40,079,000 | -4.1% | 1,926,862 | -4.6% | 0.55% | -17.1% |
| Q4 2016 | $41,788,000 | +41.4% | 2,018,729 | +10.7% | 0.66% | +22.9% |
| Q3 2016 | $29,554,000 | +30.1% | 1,823,214 | +9.2% | 0.54% | +16.7% |
| Q2 2016 | $22,712,000 | +14.6% | 1,669,992 | +47.2% | 0.46% | +4.5% |
| Q1 2016 | $19,814,000 | -1.5% | 1,134,796 | +92.8% | 0.44% | -20.0% |
| Q4 2015 | $20,108,000 | +14.9% | 588,646 | +0.1% | 0.55% | +15.1% |
| Q3 2015 | $17,501,000 | -1.0% | 588,071 | +6.3% | 0.48% | +10.9% |
| Q2 2015 | $17,684,000 | +2.3% | 552,972 | -33.7% | 0.43% | -3.8% |
| Q1 2015 | $17,284,000 | +29.5% | 833,772 | +5.8% | 0.45% | +30.6% |
| Q4 2014 | $13,347,000 | -1.7% | 787,923 | +12.2% | 0.34% | -8.0% |
| Q3 2014 | $13,580,000 | -7.9% | 702,550 | +62.1% | 0.37% | -11.2% |
| Q2 2014 | $14,738,000 | +2296.4% | 433,457 | +2119.8% | 0.42% | +2000.0% |
| Q1 2014 | $615,000 | – | 19,527 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $94,714,000 | 24.58% |
| Palo Alto Investors LP | 2,673,313 | $75,762,000 | 3.97% |
| Evolutionary Tree Capital Management, LLC | 89,348 | $2,532,000 | 1.93% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,121,152 | $31,773,000 | 1.12% |
| ArrowMark Colorado Holdings LLC | 2,964,135 | $84,004,000 | 0.65% |
| Rhenman & Partners Asset Management AB | 220,000 | $6,235,000 | 0.51% |
| Fosun International Ltd | 233,841 | $6,627,000 | 0.43% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 174,970 | $4,959,000 | 0.30% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 76,671 | $2,173,000 | 0.27% |
| Tekla Capital Management LLC | 213,808 | $6,059,000 | 0.21% |